Review




Structured Review

CapitalBio Corporation dna microarray biochip
Diagnostic profile of clinical images, histopathological findings, Ziehl-Neelsen staining, and <t>DNA</t> <t>microarray</t> chip assay of participants with cutaneous mycobacterial infections. (A-C) Skin lesions of participants with cutaneous infection of M. marinum (A) , M. abscessus (B) , MTB (C) , and M. chelonae (D) . (E, F) Hematoxylin and eosin staining revealing acanthosis, pseudoepitheliomatous hyperplasia or exocytosis, diffuse inflammatory cells infiltration in the dermis, including multinucleated giant cells (white arrow), lymphocytes, neutrophils, and plasmocytes (magnification: A, 40×; B, 200×). (G) Ziehl-Neelsen staining of isolates from skin tissue culture showing red club-shaped filaments. (H-K) Mapped images of the DNA microarray chip assay of skin tissue confirming infection with M. marinum (H) , M. abscessus (I) , MTB (J) , and M. chelonae (K) .
Dna Microarray Biochip, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/dna+microarray+chip/pmc10349391-107-1-4
Average 90 stars, based on 1 article reviews
dna microarray biochip - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection"

Article Title: DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection

Journal: Frontiers in Cellular and Infection Microbiology

doi: 10.3389/fcimb.2023.1183078

Diagnostic profile of clinical images, histopathological findings, Ziehl-Neelsen staining, and DNA microarray chip assay of participants with cutaneous mycobacterial infections. (A-C) Skin lesions of participants with cutaneous infection of M. marinum (A) , M. abscessus (B) , MTB (C) , and M. chelonae (D) . (E, F) Hematoxylin and eosin staining revealing acanthosis, pseudoepitheliomatous hyperplasia or exocytosis, diffuse inflammatory cells infiltration in the dermis, including multinucleated giant cells (white arrow), lymphocytes, neutrophils, and plasmocytes (magnification: A, 40×; B, 200×). (G) Ziehl-Neelsen staining of isolates from skin tissue culture showing red club-shaped filaments. (H-K) Mapped images of the DNA microarray chip assay of skin tissue confirming infection with M. marinum (H) , M. abscessus (I) , MTB (J) , and M. chelonae (K) .
Figure Legend Snippet: Diagnostic profile of clinical images, histopathological findings, Ziehl-Neelsen staining, and DNA microarray chip assay of participants with cutaneous mycobacterial infections. (A-C) Skin lesions of participants with cutaneous infection of M. marinum (A) , M. abscessus (B) , MTB (C) , and M. chelonae (D) . (E, F) Hematoxylin and eosin staining revealing acanthosis, pseudoepitheliomatous hyperplasia or exocytosis, diffuse inflammatory cells infiltration in the dermis, including multinucleated giant cells (white arrow), lymphocytes, neutrophils, and plasmocytes (magnification: A, 40×; B, 200×). (G) Ziehl-Neelsen staining of isolates from skin tissue culture showing red club-shaped filaments. (H-K) Mapped images of the DNA microarray chip assay of skin tissue confirming infection with M. marinum (H) , M. abscessus (I) , MTB (J) , and M. chelonae (K) .

Techniques Used: Diagnostic Assay, Staining, Microarray, Infection

Sensitivities, specificity and accuracy of the skin culture method and  DNA microarray  chip assay in the diagnosis of cutaneous mycobacterial infections.
Figure Legend Snippet: Sensitivities, specificity and accuracy of the skin culture method and DNA microarray chip assay in the diagnosis of cutaneous mycobacterial infections.

Techniques Used: Microarray, Biomarker Discovery

PLR, NLR, Youden’s index and OR of the skin tissue culture method and  DNA microarray  chip assay.
Figure Legend Snippet: PLR, NLR, Youden’s index and OR of the skin tissue culture method and DNA microarray chip assay.

Techniques Used: Microarray

Related Articles

Microarray:

Article Title: DNA microarray chip assay in new use: early diagnostic value in cutaneous mycobacterial infection
Article Snippet: .. The DNA microarray biochip (CapitalBio Company Ltd, Beijing, China) used in the study could identify 17 mycobacterial species, including M. tuberculosis , M. intracellulare , M. avium , M. gordonae , M. kansasii , M. fortuitum , M. scrofulaceum , M. gilvum , M. terrae , M. chelonae/M. abscessus , M. phlei , M. nonchromogenicum , M. marinum/M. ulcerans , M. aurum , M. szulgai/M. malmoense , M. xenopi , and M. smegmatis . ..

Article Title: Investigating a pulmonary Mycobacterium abscessus infection outbreak among elderly inpatients in the intensive care ward.
Article Snippet: .. Growing isolates were identified at the species level using a DNA microarray chip from the Mycobacterial Species Identification Array Kit (CapitalBio Technology Inc., Beijing, China) based on previous studies [32–35]. ..

Article Title: Assessing the utility of the Xpert Mycobacterium tuberculosis /rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis
Article Snippet: .. The bacterial strains were identified by the DNA microarray chip analysis (CapitalBio Technology). ..

Article Title: Identification and characterization of nontuberculous mycobacteria isolated from suspected pulmonary tuberculosis patients in eastern china from 2009 to 2019 using an identification array system
Article Snippet: Genomic DNA was extracted using the DNeasy Blood & Tissue Kit (QIAGEN, Valencia, CA, USA), following the manufacturer's protocol as previously reported. .. DNA microarray chip from Mycobacterial Species Identification Array Kit (CapitalBio Technology Inc., Beijing, China) was performed for NTM species identification as previously reported., , It can identify as many as 17 Mycobacterium species: M. tuberculosis complex, M. chelonae - M. abscessus, M. fortuitum, M. intracellulare, M. avium, M. kansasii, M. gordonae, M. terrae, M. smegmatis, M. szulgai / M. malmoense, M. nonchromogenicum, M. scrofulaceum, M. xenopi, M. aurum, M. marinum / M. ulcerans, M. gilvum , and M. phlei ( ). .. Hybridization patterns of representative strains on the probe array (Mycobacterial Species Identification Array Kit (CapitalBio Technology Inc., Beijing, China)).

other:

Article Title: Analysis of the application of a gene chip method for detecting Mycobacterium tuberculosis drug resistance in clinical specimens: a retrospective study
Article Snippet: The CapitalBio DNA microarray chip method is used to qualitatively detect nucleic acids in samples of Mtb isolates from clinical TB patients.



Similar Products

90
CapitalBio Corporation capitalbio dna microarray
Capitalbio Dna Microarray, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/capitalbio++dna+microarray/pm38850839-299-11-11
Average 90 stars, based on 1 article reviews
capitalbio dna microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation capitalbio™ dna microarray
Overall sensitivity of the <t> DNA microarray </t> for the M. tuberculosis strains identification
Capitalbio™ Dna Microarray, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/capitalbio++dna+microarray/pmc03527135-8-21-20
Average 90 stars, based on 1 article reviews
capitalbio™ dna microarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation dna microarray capitalbio
The ROC curve of the CapitalBio <t>DNA</t> <t>microarray</t> for detecting RFP resistance. ROC, receiver operating characteristic; RFP, rifampicin.
Dna Microarray Capitalbio, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/capitalbio++dna+microarray/pmc08339777-99-6-8
Average 90 stars, based on 1 article reviews
dna microarray capitalbio - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation dna microarray capitalbio human lncrna array v4
The ROC curve of the CapitalBio <t>DNA</t> <t>microarray</t> for detecting RFP resistance. ROC, receiver operating characteristic; RFP, rifampicin.
Dna Microarray Capitalbio Human Lncrna Array V4, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/human+lncrna+array+v4/pmc06487373__mmc1-55-2-4
Average 90 stars, based on 1 article reviews
dna microarray capitalbio human lncrna array v4 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation dna microarray capitalbio (tm)
The ROC curve of the CapitalBio <t>DNA</t> <t>microarray</t> for detecting RFP resistance. ROC, receiver operating characteristic; RFP, rifampicin.
Dna Microarray Capitalbio (Tm), supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/capitalbio+dna+microarray/capitalbio++dna+microarray/pm29420022-311-20-18
Average 90 stars, based on 1 article reviews
dna microarray capitalbio (tm) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Overall sensitivity of the  DNA microarray  for the M. tuberculosis strains identification

Journal: BMC Infectious Diseases

Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study

doi: 10.1186/1471-2334-12-303

Figure Lengend Snippet: Overall sensitivity of the DNA microarray for the M. tuberculosis strains identification

Article Snippet: Specimens collected during surgery from the tuberculosis patients were subjected to M. tuberculosis species identification and drug-resistance detection by the CapitalBio™ DNA microarray, and results were compared with those obtained from the absolute concentration drug susceptibility testing.

Techniques: Microarray

Hybridization pattern of spinal tuberculosis specimens with the DNA microarray. a . Hybridization pattern of the M. tuberculosis strain identification (white frame) b . RMP resistance with the rpoB 531 (T C G->T T G) mutation, the hybridization signal of probe TCG531TTG (solid rectangle) being higher than corresponding wild-type probe (dashed rectangle) c . RMP resistance test: rpoB 516 (G A C->G T C) mutation, the hybridization signal of probe GAC516GTC (solid rectangle) being higher than corresponding wild-type probe (dashed rectangle) d , e . INH resistance test: katG 315 (A G C->A C C) mutation, the hybridisation signal of probe katG AGC315ACC (solid rectangles) were higher than corresponding wild-type probe (dashed rectangles) e. INH resistance test: inhA -15 C-T mutation, the hybridisation signal of probe inhA 15C→T (solid rectangles) were higher than corresponding wild-type probe (dashed rectangles).

Journal: BMC Infectious Diseases

Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study

doi: 10.1186/1471-2334-12-303

Figure Lengend Snippet: Hybridization pattern of spinal tuberculosis specimens with the DNA microarray. a . Hybridization pattern of the M. tuberculosis strain identification (white frame) b . RMP resistance with the rpoB 531 (T C G->T T G) mutation, the hybridization signal of probe TCG531TTG (solid rectangle) being higher than corresponding wild-type probe (dashed rectangle) c . RMP resistance test: rpoB 516 (G A C->G T C) mutation, the hybridization signal of probe GAC516GTC (solid rectangle) being higher than corresponding wild-type probe (dashed rectangle) d , e . INH resistance test: katG 315 (A G C->A C C) mutation, the hybridisation signal of probe katG AGC315ACC (solid rectangles) were higher than corresponding wild-type probe (dashed rectangles) e. INH resistance test: inhA -15 C-T mutation, the hybridisation signal of probe inhA 15C→T (solid rectangles) were higher than corresponding wild-type probe (dashed rectangles).

Article Snippet: Specimens collected during surgery from the tuberculosis patients were subjected to M. tuberculosis species identification and drug-resistance detection by the CapitalBio™ DNA microarray, and results were compared with those obtained from the absolute concentration drug susceptibility testing.

Techniques: Hybridization, Microarray, Mutagenesis

Performance of the  DNA microarray  assay for detection of resistance to INH and RMP compared with phenotypic DST

Journal: BMC Infectious Diseases

Article Title: Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: A prospective validation study

doi: 10.1186/1471-2334-12-303

Figure Lengend Snippet: Performance of the DNA microarray assay for detection of resistance to INH and RMP compared with phenotypic DST

Article Snippet: Specimens collected during surgery from the tuberculosis patients were subjected to M. tuberculosis species identification and drug-resistance detection by the CapitalBio™ DNA microarray, and results were compared with those obtained from the absolute concentration drug susceptibility testing.

Techniques: Microarray

The ROC curve of the CapitalBio DNA microarray for detecting RFP resistance. ROC, receiver operating characteristic; RFP, rifampicin.

Journal: Journal of Thoracic Disease

Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis

doi: 10.21037/jtd-21-913

Figure Lengend Snippet: The ROC curve of the CapitalBio DNA microarray for detecting RFP resistance. ROC, receiver operating characteristic; RFP, rifampicin.

Article Snippet: Microarray hybridization was based on CapitalBio DNA microarray (CapitalBio Corp., Beijing, China).

Techniques: Microarray

Diagnostic performance of  DNA microarray  for RFP resistance

Journal: Journal of Thoracic Disease

Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis

doi: 10.21037/jtd-21-913

Figure Lengend Snippet: Diagnostic performance of DNA microarray for RFP resistance

Article Snippet: Microarray hybridization was based on CapitalBio DNA microarray (CapitalBio Corp., Beijing, China).

Techniques: Diagnostic Assay, Microarray

The ROC curve of the CapitalBio DNA microarray for detecting INH resistance. ROC, receiver operating characteristic; IHN, isonicotinic acid hydrazide.

Journal: Journal of Thoracic Disease

Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis

doi: 10.21037/jtd-21-913

Figure Lengend Snippet: The ROC curve of the CapitalBio DNA microarray for detecting INH resistance. ROC, receiver operating characteristic; IHN, isonicotinic acid hydrazide.

Article Snippet: Microarray hybridization was based on CapitalBio DNA microarray (CapitalBio Corp., Beijing, China).

Techniques: Microarray

Diagnostic performance of  DNA microarray  for INH resistance

Journal: Journal of Thoracic Disease

Article Title: Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis

doi: 10.21037/jtd-21-913

Figure Lengend Snippet: Diagnostic performance of DNA microarray for INH resistance

Article Snippet: Microarray hybridization was based on CapitalBio DNA microarray (CapitalBio Corp., Beijing, China).

Techniques: Diagnostic Assay, Microarray